Griveau Louise, Bouvet Marion, Christin Emilie, Paret Cloé, Lecoq Lauriane, Radix Sylvie, Laumonier Thomas, Sohier Jerome, Gache Vincent
Laboratory of Tissue Biology and Therapeutic Engineering, CNRS, University of Lyon, Claude Bernard University Lyon 1, UMR5305 LBTI, Lyon, France.
Institut NeuroMyoGène, Unité Physiopathologie et Génétique du Neurone et du Muscle, INSERM U1513, CNRS UMR 5261, Université Claude Bernard Lyon 1, Univ Lyon, Lyon, France.
J Tissue Eng. 2024 Nov 4;15:20417314241283148. doi: 10.1177/20417314241283148. eCollection 2024 Jan-Dec.
In severe skeletal muscle damage, muscle tissue regeneration process has to face the loss of resident muscle stem cells (MuSCs) and the lack of connective tissue necessary to guide the regeneration process. Biocompatible and standardized 3D structures that can be injected to the muscle injury site, conforming to the defect shape while actively guiding the repair process, holds great promise for skeletal muscle tissue regeneration. In this study, we explore the use of an injectable and porous lysine dendrimer/polyethylene glycol (DGL/PEG) hydrogel as an acellular support for skeletal muscle regeneration. We adjusted the DGL/PEG composition to achieve a stiffness conducive to the attachment and proliferation of murine immortalized myoblasts and human primary muscle stems cells, sustaining the formation and maturation of muscle fibers . We then evaluated the potential of one selected "myogenic-porous hydrogel" as a supportive structure for muscle repair in a large muscle defect in rats. This injectable and porous formulation filled the defect, promoting rapid cellularization with the presence of endothelial cells, macrophages, and myoblasts, thereby supporting neo-myogenesis more specifically at the interface between the wound edges and the hydrogel. The selected porous DGL/PEG hydrogel acted as a guiding scaffold at the periphery of the defect, facilitating the formation and anchorage of aligned muscle fibers 21 days after injury. Overall, our results indicate DGL/PEG porous injectable hydrogel potential to create a pro-regenerative environment for muscle cells after large skeletal muscle injuries, paving the way for acellular treatment in regenerative muscle medicine.
在严重的骨骼肌损伤中,肌肉组织再生过程必须面对驻留肌肉干细胞(MuSCs)的丧失以及引导再生过程所需的结缔组织的缺乏。能够注射到肌肉损伤部位、符合缺损形状并在积极引导修复过程的同时具有生物相容性和标准化的3D结构,对骨骼肌组织再生具有巨大潜力。在本研究中,我们探索使用可注射的多孔赖氨酸树枝状大分子/聚乙二醇(DGL/PEG)水凝胶作为骨骼肌再生的无细胞支架。我们调整了DGL/PEG的组成,以实现有利于小鼠永生化成肌细胞和人原代肌肉干细胞附着和增殖的硬度,维持肌纤维的形成和成熟。然后,我们评估了一种选定的“成肌多孔水凝胶”作为大鼠大肌肉缺损肌肉修复支持结构的潜力。这种可注射的多孔制剂填充了缺损,在内皮细胞、巨噬细胞和成肌细胞存在的情况下促进了快速细胞化,从而更具体地在伤口边缘与水凝胶之间的界面处支持新的肌生成。选定的多孔DGL/PEG水凝胶在缺损周边充当引导支架,促进损伤后21天排列整齐的肌纤维的形成和锚定。总体而言,我们的结果表明DGL/PEG多孔可注射水凝胶有潜力在大型骨骼肌损伤后为肌肉细胞创造一个促进再生的环境,为再生肌肉医学中的无细胞治疗铺平道路。